WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report) shares fell 0.3% during mid-day trading on Thursday . The stock traded as low as $23.84 and last traded at $23.84. 424 shares changed hands during mid-day trading, a decline of 66% from the average daily volume of 1,239 shares. The stock had previously closed at $23.90.
WisdomTree BioRevolution Fund Stock Down 0.3%
The company has a market capitalization of $3.58 million, a P/E ratio of 17.03 and a beta of 1.01. The business has a fifty day moving average price of $20.80 and a 200 day moving average price of $18.85.
Institutional Investors Weigh In On WisdomTree BioRevolution Fund
A hedge fund recently raised its stake in WisdomTree BioRevolution Fund stock. Flow Traders U.S. LLC grew its position in shares of WisdomTree BioRevolution Fund (BATS:WDNA – Free Report) by 59.0% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 26,182 shares of the company’s stock after acquiring an additional 9,720 shares during the quarter. Flow Traders U.S. LLC owned 17.45% of WisdomTree BioRevolution Fund worth $416,000 at the end of the most recent reporting period.
WisdomTree BioRevolution Fund Company Profile
The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.
Further Reading
- Five stocks we like better than WisdomTree BioRevolution Fund
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.
